This mini-review paper does not consider classical work concerning the formation of inclusion complexes between
pharmaceuticals and cyclodextrins. Instead, it highlights recent reports concerning the association of these
host:guest systems with other carrier systems such as liposomes and nanoparticles showing the state of art of this subject
with examples of developed systems and the advantages of these strategy in order to be potential systems as drug carriers.
Keywords: Cyclodextrin, liposome, nanoparticle, drug delivery.
Rights & PermissionsPrintExport